Investigational Site Number :7920009

Ankara 06200

0 studies enrolling now · 3 studies all time

What they study most

Breast Cancer, Plasma Cell Myeloma Recurrent, Primary Progressive Multiple Sclerosis

Studies at this site

• Primary Progressive Multiple Sclerosis (PPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (PERSEUS) — Completed
• SC Versus IV Isatuximab in Combination With Pomalidomide and Dexamethasone in RRMM — Running, not enrolling
• Amcenestrant (SAR439859) Plus Palbociclib as First Line Therapy for Patients With ER (+) HER2(-) Advanced Breast Cancer — Stopped early